Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer：A Retrospective Real World Study

NCT05979623 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT05979623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05979623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer：A Retrospective Real World Study
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2016
Completion date
December 31, 2022
Enrollment
971 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ib non-small cell lung carcinoma